APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sarcoma Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sarcoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchSarcoma Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Sarcoma Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Sarcoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sarcoma Treatment Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Sarcoma Treatment Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Sarcoma Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sarcoma Treatment include Eisai Co., Ltd., Teva Pharmaceuticals, Johnson and Johnson, Novartis AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline and Fresenius Kabi AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Sarcoma Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sarcoma Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sarcoma Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sarcoma Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Sarcoma Treatment Segment by Company

Eisai Co., Ltd.

Teva Pharmaceuticals

Johnson and Johnson

Novartis AG

Merck & Co., Inc.

Eli Lilly and Company

Pfizer Inc.

GlaxoSmithKline

Fresenius Kabi AG

Daiichi Sankyo Company Limited

Bayer AG

Bristol-Myers Squibb Company

F.Hoffmann-La Roche AG

Epizyme, Inc.

Baxter Healthcare Corporation

AgonOX, Inc.

Sarcoma Treatment Segment by Type

Stable Isotope

Radioisotope

Sarcoma Treatment Segment by Application

Others

Hospital

Laboratory

Sarcoma Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sarcoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sarcoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sarcoma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sarcoma Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sarcoma Treatment industry.

Chapter 3: Detailed analysis of Sarcoma Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sarcoma Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sarcoma Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Stable Isotope Table 3. Key Players of Radioisotope Table 4. Global Sarcoma Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Others Table 6. Key Players of Hospital Table 7. Key Players of Laboratory Table 8. Global Sarcoma Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Sarcoma Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Sarcoma Treatment Market Share by Region (2021-2026) Table 11. Global Sarcoma Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Sarcoma Treatment Market Share by Region (2027-2032) Table 13. Sarcoma Treatment Industry Trends Table 14. Sarcoma Treatment Industry Drivers Table 15. Sarcoma Treatment Industry Opportunities and Challenges Table 16. Sarcoma Treatment Industry Restraints Table 17. Global Sarcoma Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Sarcoma Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Sarcoma Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Sarcoma Treatment Key Company Head Office and Area Served Table 21. Global Sarcoma Treatment Company, Product Type & Application Table 22. Global Sarcoma Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Sarcoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Sarcoma Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Sarcoma Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Sarcoma Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Sarcoma Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Sarcoma Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Sarcoma Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Sarcoma Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Sarcoma Treatment Revenue Market Share by Application (2027-2032) Table 35. Eisai Co., Ltd. Company Information Table 36. Eisai Co., Ltd. Business Overview Table 37. Eisai Co., Ltd. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Eisai Co., Ltd. Sarcoma Treatment Product Portfolio Table 39. Eisai Co., Ltd. Recent Development Table 40. Teva Pharmaceuticals Company Information Table 41. Teva Pharmaceuticals Business Overview Table 42. Teva Pharmaceuticals Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Pharmaceuticals Sarcoma Treatment Product Portfolio Table 44. Teva Pharmaceuticals Recent Development Table 45. Johnson and Johnson Company Information Table 46. Johnson and Johnson Business Overview Table 47. Johnson and Johnson Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Johnson and Johnson Sarcoma Treatment Product Portfolio Table 49. Johnson and Johnson Recent Development Table 50. Novartis AG Company Information Table 51. Novartis AG Business Overview Table 52. Novartis AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis AG Sarcoma Treatment Product Portfolio Table 54. Novartis AG Recent Development Table 55. Merck & Co., Inc. Company Information Table 56. Merck & Co., Inc. Business Overview Table 57. Merck & Co., Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Merck & Co., Inc. Sarcoma Treatment Product Portfolio Table 59. Merck & Co., Inc. Recent Development Table 60. Eli Lilly and Company Company Information Table 61. Eli Lilly and Company Business Overview Table 62. Eli Lilly and Company Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Eli Lilly and Company Sarcoma Treatment Product Portfolio Table 64. Eli Lilly and Company Recent Development Table 65. Pfizer Inc. Company Information Table 66. Pfizer Inc. Business Overview Table 67. Pfizer Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer Inc. Sarcoma Treatment Product Portfolio Table 69. Pfizer Inc. Recent Development Table 70. GlaxoSmithKline Company Information Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GlaxoSmithKline Sarcoma Treatment Product Portfolio Table 74. GlaxoSmithKline Recent Development Table 75. Fresenius Kabi AG Company Information Table 76. Fresenius Kabi AG Business Overview Table 77. Fresenius Kabi AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Fresenius Kabi AG Sarcoma Treatment Product Portfolio Table 79. Fresenius Kabi AG Recent Development Table 80. Daiichi Sankyo Company Limited Company Information Table 81. Daiichi Sankyo Company Limited Business Overview Table 82. Daiichi Sankyo Company Limited Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Daiichi Sankyo Company Limited Sarcoma Treatment Product Portfolio Table 84. Daiichi Sankyo Company Limited Recent Development Table 85. Bayer AG Company Information Table 86. Bayer AG Business Overview Table 87. Bayer AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Bayer AG Sarcoma Treatment Product Portfolio Table 89. Bayer AG Recent Development Table 90. Bristol-Myers Squibb Company Company Information Table 91. Bristol-Myers Squibb Company Business Overview Table 92. Bristol-Myers Squibb Company Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bristol-Myers Squibb Company Sarcoma Treatment Product Portfolio Table 94. Bristol-Myers Squibb Company Recent Development Table 95. F.Hoffmann-La Roche AG Company Information Table 96. F.Hoffmann-La Roche AG Business Overview Table 97. F.Hoffmann-La Roche AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. F.Hoffmann-La Roche AG Sarcoma Treatment Product Portfolio Table 99. F.Hoffmann-La Roche AG Recent Development Table 100. Epizyme, Inc. Company Information Table 101. Epizyme, Inc. Business Overview Table 102. Epizyme, Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Epizyme, Inc. Sarcoma Treatment Product Portfolio Table 104. Epizyme, Inc. Recent Development Table 105. Baxter Healthcare Corporation Company Information Table 106. Baxter Healthcare Corporation Business Overview Table 107. Baxter Healthcare Corporation Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Baxter Healthcare Corporation Sarcoma Treatment Product Portfolio Table 109. Baxter Healthcare Corporation Recent Development Table 110. AgonOX, Inc. Company Information Table 111. AgonOX, Inc. Business Overview Table 112. AgonOX, Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. AgonOX, Inc. Sarcoma Treatment Product Portfolio Table 114. AgonOX, Inc. Recent Development Table 115. North America Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Sarcoma Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Sarcoma Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Sarcoma Treatment Market Size by Country (2021-2026) Table 121. North America Sarcoma Treatment Market Size by Country (2027-2032) Table 122. Europe Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Sarcoma Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Sarcoma Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Sarcoma Treatment Market Size by Country (2021-2026) Table 128. Europe Sarcoma Treatment Market Size by Country (2027-2032) Table 129. China Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 130. China Sarcoma Treatment Market Size by Type (2027-2032) & (US$ Million) Table 131. China Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 132. China Sarcoma Treatment Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Sarcoma Treatment Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Sarcoma Treatment Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Sarcoma Treatment Market Size by Country (2021-2026) Table 139. Asia Sarcoma Treatment Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Sarcoma Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Sarcoma Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Sarcoma Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Sarcoma Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Sarcoma Treatment Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Sarcoma Treatment Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Sarcoma Treatment Product Image Figure 2. Global Sarcoma Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sarcoma Treatment Market Share by Type: 2025 VS 2032 Figure 4. Stable Isotope Image Figure 5. Radioisotope Image Figure 6. Global Sarcoma Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Sarcoma Treatment Market Share by Application: 2025 VS 2032 Figure 8. Others Image Figure 9. Hospital Image Figure 10. Laboratory Image Figure 11. Global Sarcoma Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Sarcoma Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Sarcoma Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Sarcoma Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Sarcoma Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Sarcoma Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Sarcoma Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Sarcoma Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Sarcoma Treatment Market Share by Type (2021-2032) Figure 24. North America Sarcoma Treatment Market Share by Application (2021-2032) Figure 25. North America Sarcoma Treatment Market Share by Country (2021-2032) Figure 26. United States Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Sarcoma Treatment Market Share by Type (2021-2032) Figure 31. Europe Sarcoma Treatment Market Share by Application (2021-2032) Figure 32. Europe Sarcoma Treatment Market Share by Country (2021-2032) Figure 33. Germany Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Sarcoma Treatment Market Share by Type (2021-2032) Figure 41. China Sarcoma Treatment Market Share by Application (2021-2032) Figure 42. Asia Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Sarcoma Treatment Market Share by Type (2021-2032) Figure 44. Asia Sarcoma Treatment Market Share by Application (2021-2032) Figure 45. Asia Sarcoma Treatment Market Share by Country (2021-2032) Figure 46. Japan Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Sarcoma Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Sarcoma Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Sarcoma Treatment Market Share by Country (2021-2032) Figure 56. Brazil Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotope
  • Radioisotope
Applications
  • Others
  • Hospital
  • Laboratory
Companies covered
  • Eisai Co., Ltd.
  • Teva Pharmaceuticals
  • Johnson and Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Pfizer Inc.
  • GlaxoSmithKline
  • Fresenius Kabi AG
  • Daiichi Sankyo Company Limited
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F.Hoffmann-La Roche AG
  • Epizyme, Inc.
  • Baxter Healthcare Corporation
  • AgonOX, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sarcoma Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Stable Isotope
  5. 1.2.3 Radioisotope
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Sarcoma Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Others
  9. 1.3.3 Hospital
  10. 1.3.4 Laboratory
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Sarcoma Treatment Growth Trends by Region
  13. 1.5.1 Global Sarcoma Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Sarcoma Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Sarcoma Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Sarcoma Treatment Market Dynamics
  1. 2.1 Sarcoma Treatment Industry Trends
  2. 2.2 Sarcoma Treatment Industry Drivers
  3. 2.3 Sarcoma Treatment Industry Opportunities and Challenges
  4. 2.4 Sarcoma Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sarcoma Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Sarcoma Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sarcoma Treatment Key Company Head office and Area Served
  4. 3.4 Global Sarcoma Treatment Company, Product Type & Application
  5. 3.5 Global Sarcoma Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sarcoma Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sarcoma Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sarcoma Treatment Tier 1, Tier 2, and Tier 3
4 Sarcoma Treatment Market by Type
  1. 4.1 Global Sarcoma Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sarcoma Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Sarcoma Treatment Market Size Share by Type (2021-2032)
5 Sarcoma Treatment Market by Application
  1. 5.1 Global Sarcoma Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sarcoma Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Sarcoma Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eisai Co., Ltd.
  2. 6.1.1 Eisai Co., Ltd. Company Information
  3. 6.1.2 Eisai Co., Ltd. Business Overview
  4. 6.1.3 Eisai Co., Ltd. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eisai Co., Ltd. Sarcoma Treatment Product Portfolio
  6. 6.1.5 Eisai Co., Ltd. Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Sarcoma Treatment Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 Johnson and Johnson
  14. 6.3.1 Johnson and Johnson Company Information
  15. 6.3.2 Johnson and Johnson Business Overview
  16. 6.3.3 Johnson and Johnson Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson and Johnson Sarcoma Treatment Product Portfolio
  18. 6.3.5 Johnson and Johnson Recent Developments
  19. 6.4 Novartis AG
  20. 6.4.1 Novartis AG Company Information
  21. 6.4.2 Novartis AG Business Overview
  22. 6.4.3 Novartis AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis AG Sarcoma Treatment Product Portfolio
  24. 6.4.5 Novartis AG Recent Developments
  25. 6.5 Merck & Co., Inc.
  26. 6.5.1 Merck & Co., Inc. Company Information
  27. 6.5.2 Merck & Co., Inc. Business Overview
  28. 6.5.3 Merck & Co., Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck & Co., Inc. Sarcoma Treatment Product Portfolio
  30. 6.5.5 Merck & Co., Inc. Recent Developments
  31. 6.6 Eli Lilly and Company
  32. 6.6.1 Eli Lilly and Company Company Information
  33. 6.6.2 Eli Lilly and Company Business Overview
  34. 6.6.3 Eli Lilly and Company Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eli Lilly and Company Sarcoma Treatment Product Portfolio
  36. 6.6.5 Eli Lilly and Company Recent Developments
  37. 6.7 Pfizer Inc.
  38. 6.7.1 Pfizer Inc. Company Information
  39. 6.7.2 Pfizer Inc. Business Overview
  40. 6.7.3 Pfizer Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Inc. Sarcoma Treatment Product Portfolio
  42. 6.7.5 Pfizer Inc. Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GlaxoSmithKline Sarcoma Treatment Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Fresenius Kabi AG
  50. 6.9.1 Fresenius Kabi AG Company Information
  51. 6.9.2 Fresenius Kabi AG Business Overview
  52. 6.9.3 Fresenius Kabi AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Fresenius Kabi AG Sarcoma Treatment Product Portfolio
  54. 6.9.5 Fresenius Kabi AG Recent Developments
  55. 6.10 Daiichi Sankyo Company Limited
  56. 6.10.1 Daiichi Sankyo Company Limited Company Information
  57. 6.10.2 Daiichi Sankyo Company Limited Business Overview
  58. 6.10.3 Daiichi Sankyo Company Limited Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Daiichi Sankyo Company Limited Sarcoma Treatment Product Portfolio
  60. 6.10.5 Daiichi Sankyo Company Limited Recent Developments
  61. 6.11 Bayer AG
  62. 6.11.1 Bayer AG Company Information
  63. 6.11.2 Bayer AG Business Overview
  64. 6.11.3 Bayer AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer AG Sarcoma Treatment Product Portfolio
  66. 6.11.5 Bayer AG Recent Developments
  67. 6.12 Bristol-Myers Squibb Company
  68. 6.12.1 Bristol-Myers Squibb Company Company Information
  69. 6.12.2 Bristol-Myers Squibb Company Business Overview
  70. 6.12.3 Bristol-Myers Squibb Company Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bristol-Myers Squibb Company Sarcoma Treatment Product Portfolio
  72. 6.12.5 Bristol-Myers Squibb Company Recent Developments
  73. 6.13 F.Hoffmann-La Roche AG
  74. 6.13.1 F.Hoffmann-La Roche AG Company Information
  75. 6.13.2 F.Hoffmann-La Roche AG Business Overview
  76. 6.13.3 F.Hoffmann-La Roche AG Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 F.Hoffmann-La Roche AG Sarcoma Treatment Product Portfolio
  78. 6.13.5 F.Hoffmann-La Roche AG Recent Developments
  79. 6.14 Epizyme, Inc.
  80. 6.14.1 Epizyme, Inc. Company Information
  81. 6.14.2 Epizyme, Inc. Business Overview
  82. 6.14.3 Epizyme, Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Epizyme, Inc. Sarcoma Treatment Product Portfolio
  84. 6.14.5 Epizyme, Inc. Recent Developments
  85. 6.15 Baxter Healthcare Corporation
  86. 6.15.1 Baxter Healthcare Corporation Company Information
  87. 6.15.2 Baxter Healthcare Corporation Business Overview
  88. 6.15.3 Baxter Healthcare Corporation Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Baxter Healthcare Corporation Sarcoma Treatment Product Portfolio
  90. 6.15.5 Baxter Healthcare Corporation Recent Developments
  91. 6.16 AgonOX, Inc.
  92. 6.16.1 AgonOX, Inc. Company Information
  93. 6.16.2 AgonOX, Inc. Business Overview
  94. 6.16.3 AgonOX, Inc. Sarcoma Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 AgonOX, Inc. Sarcoma Treatment Product Portfolio
  96. 6.16.5 AgonOX, Inc. Recent Developments
7 North America
  1. 7.1 North America Sarcoma Treatment Market Size (2021-2032)
  2. 7.2 North America Sarcoma Treatment Market Size by Type
  3. 7.2.1 North America Sarcoma Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Sarcoma Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Sarcoma Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Sarcoma Treatment Market Size by Application
  7. 7.3.1 North America Sarcoma Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Sarcoma Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Sarcoma Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Sarcoma Treatment Market Size by Country
  11. 7.4.1 North America Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sarcoma Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Sarcoma Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Sarcoma Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sarcoma Treatment Market Size (2021-2032)
  2. 8.2 Europe Sarcoma Treatment Market Size by Type
  3. 8.2.1 Europe Sarcoma Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sarcoma Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sarcoma Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Sarcoma Treatment Market Size by Application
  7. 8.3.1 Europe Sarcoma Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sarcoma Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sarcoma Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Sarcoma Treatment Market Size by Country
  11. 8.4.1 Europe Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sarcoma Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sarcoma Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sarcoma Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sarcoma Treatment Market Size (2021-2032)
  2. 9.2 China Sarcoma Treatment Market Size by Type
  3. 9.2.1 China Sarcoma Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Sarcoma Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Sarcoma Treatment Market Share by Type (2021-2032)
  6. 9.3 China Sarcoma Treatment Market Size by Application
  7. 9.3.1 China Sarcoma Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Sarcoma Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Sarcoma Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sarcoma Treatment Market Size (2021-2032)
  2. 10.2 Asia Sarcoma Treatment Market Size by Type
  3. 10.2.1 Asia Sarcoma Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sarcoma Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sarcoma Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Sarcoma Treatment Market Size by Application
  7. 10.3.1 Asia Sarcoma Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sarcoma Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sarcoma Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Sarcoma Treatment Market Size by Country
  11. 10.4.1 Asia Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sarcoma Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sarcoma Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sarcoma Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sarcoma Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sarcoma Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sarcoma Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sarcoma Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sarcoma Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sarcoma Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sarcoma Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sarcoma Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sarcoma Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sarcoma Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sarcoma Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sarcoma Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sarcoma Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sarcoma Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst